Navigation Links
New Research Covers Current Trends and Future Directions of the High Performing Pharmaceutical District Sales Managers

CHAPEL HILL, N.C., July 10 /PRNewswire/ -- "The DMs will be the key to evolving the future sales model," a sales leader said in Best Practices, LLC's latest report. The research establishes that the District Sales Manager (DM) is the cornerstone of pharmaceutical sales force effectiveness. Continued field force success depends largely on the ability of companies to evolve their DM positions to meet the needs of the complex, fast-changing bio-pharma industry.

Best Practices, LLC initiated this research to help executives who oversee or train bio-pharmaceutical field sales staff to understand how industry pressures are accelerating sales force evolution and impacting district manager effectiveness. Executives can use the forward-looking benchmarks in this report to plan and implement changes needed to help DMs sustain high performance levels.

Report excerpt, "The High Performing Pharmaceutical District Sales Manager: Current Trends & Future Directions," is available at

Sample key findings that emerged from this research are the following:

-- The DM Role Is Expected to Become a More Strategic Position -- Time & Resources Are Shifting from Tactical to Strategic Activities

-- Regional Managers Are a Source of Untapped Productivity -- Regional Managers Are the First Source of Change

The cross-industry report covers 26 leading bio-pharma companies and interviewed forty-six managers and executives. Participants included Amgen, Eli Lilly, Roche, Sanofi-Aventis, Merck, Abbott and Wyeth.

For more information, on Best Practices, LLC's research and services, contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients
2. Cool, Dry Air Blown Under Football Shoulder Pads Reduces Body Temperature and Heart Rate, New Research Finds
3. Cool, air blown under football shoulder pads reduces body temperature and heart rate, research finds
4. NOTES research activities increase with grants from Olympus medical Systems totaling $1 million
5. Researchers Gather to Address New Tools in Development for Breast Cancer Detection
6. Global Industry Analysts' Releases a Series of Medical Market Research Reports
7. UAB joins elite brain cancer research group
8. Lehigh to lead $9.6M national research center for serious behavior disorders
9. Some drugs increase risk of falling: UNC researchers
10. URMC, FDA to collaborate on national data repository for heart research
11. HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: